|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
JPRN |
|
Last refreshed on:
|
17 October 2023 |
|
Main ID: |
JPRN-UMIN000015133 |
|
Date of registration:
|
12/09/2014 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Development of novel biomarkers of neurodegenerative diseases-comprehensive analysis of the proteins and the RNAs in exosomes extracted from cerebrospinal fluid and urine
|
|
Scientific title:
|
Development of novel biomarkers of neurodegenerative diseases-comprehensive analysis of the proteins and the RNAs in exosomes extracted from cerebrospinal fluid and urine - Development of novel biomarkers in exosomes extracted from cerebrospinal fluid and urine |
|
Date of first enrolment:
|
2014/10/01 |
|
Target sample size:
|
130 |
|
Recruitment status: |
Recruiting |
|
URL:
|
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017525 |
|
Study type:
|
Interventional |
|
Study design:
|
Single arm Non-randomized
|
|
Phase:
|
Not applicable
|
|
|
Countries of recruitment
|
|
Japan
| | | | | | | |
|
Contacts
|
|
Name:
|
Hiroshi Doi |
|
Address:
|
3-9 Fukuura, Kanazawa-ku, Yokohama, Japan
Japan |
|
Telephone:
|
045-787-2511 |
|
Email:
|
doi@rkd.d-bs.com |
|
Affiliation:
|
Yokohama City University Department of Neurology and Stroke Medicine |
|
|
Name:
|
Hiroshi Doi |
|
Address:
|
3-9 Fukuura, Kanazawa-ku, Yokohama, Japan
Japan |
|
Telephone:
|
045-787-2511 |
|
Email:
|
doi@rkd.d-bs.com |
|
Affiliation:
|
Yokohama City University Department of Neurology and Stroke Medicine |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria:
Exclusion criteria: The participants are not limited by the age or gender.
Age minimum:
Not applicable
Age maximum:
Not applicable
Gender:
Male and Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Neurodegenerative diseases including amyotrophic lateral sclerosis, Parkinson disease, multiple system atrophy, progressive supranuclear palsy, corticobasal syndrome
|
|
Intervention(s)
|
|
Examination of cerebrospinal fluid and urine will be conducted, but no interventions are planned.
|
|
Primary Outcome(s)
|
|
Identification of novel biomarkers
|
|
Source(s) of Monetary Support
|
|
Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program, MEXT Japan Establishment of Research Center for Clinical Proteomics of Post-translational Modifications
|
|
Ethics review
|
Status: YES
Approval date:
Contact:
|
|
Results
|
|
Results available:
|
Yes |
|
Date Posted:
|
|
|
Date Completed:
|
30/09/2019 |
|
URL:
|
|
|
|